Modification of cisplatin toxicity with diethyldithiocarbamate.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Clinical Oncology

• Publication date

  1990-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1200/JCO.1990.8.9.1585PMID 2167955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in the management of nausea and vomiting caused by antineoplastic agents.

  1989cited by this paper
• Diethyldithiocarbamate modulation of murine bone marrow toxicity induced by cis-diammine(cyclobutanedicarboxylato)platinum (II).

  1989cited by this paper
• Recent advances in the management of nausea and vomiting caused by antineoplastic agents.

  1989cited by this paper
• High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations

  1989cited by this paper
• Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.

  1989cited by this paper
• Whither the modulation of platinum?

  1988cited by this paper
• Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

  1988cited by this paper
• Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin.

  1988cited by this paper
• Whither carboplatin?--A replacement for or an alternative to cisplatin?

  1987cited by this paper
• Whither carboplatin?--A replacement for or an alternative to cisplatin?

  1987cited by this paper
• WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

  1987cited by this paper
• Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.

  1987cited by this paper
• Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.

  1986cited by this paper
• Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.

  1986cited by this paper
• High-dose cisplatin therapy in ovarian cancer.

  1985cited by this paper
• Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.

  1984cited by this paper
• High-dose cisplatin in hypertonic saline.

  1984cited by this paper
• Intraperitoneal cisplatin with systemic thiosulfate protection.

  1982cited by this paper
• Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

  1981cited by this paper
• Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model.

  1980cited by this paper
• Cisplatin : current status and new developments

  1980cited by this paper
• 24‐Hour infusion of cis‐platinum in head and neck cancers

  1978cited by this paper
• cis-Platinum ototoxicity.

  1978cited by this paper
• High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis

  1977cited by this paper
• The treatment of acute nickel carbonyl poisoning with sodium diethyldithiocarbamate.

  1971cited by this paper
• The treatment of acute nickel carbonyl poisoning with sodium diethyldithiocarbamate.

  1971cited by this paper

• Preventing Cisplatin-Induced Hearing Loss in Adults: A Systematic Review and Meta-Analysis

  2025cites this paper
• Advances in anticancer applications of platinum(II) complexes of dithiocarbamates

  2024cites this paper
• Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches

  2024cites this paper
• Chelate-functionalized magnetic micelles for sequestration of cisplatin

  2023cites this paper
• Preventive effects of garlic powder on cisplatin-induced nephrotoxicity in male wister rats

  2022cites this paper
• Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy

  2021cites this paper
• RETRACTED: Anti-liver cancer activity evaluation of a polyoxometalate-organic co-crystal compound and its related coordination polymer

  2019cites this paper
• GMDTC attenuates cisplatin-induced systemic toxicity without affecting antitumor efficacy.

  2019cites this paper
• Improving the safety of metal-based drugs by tuning their metabolism with chemoprotective agents.

  2018cites this paper
• Evaluation of geranylgeranylacetone against cisplatin-induced ototoxicity by auditory brainstem response, heat shock proteins and oxidative levels in guinea pigs.

  2017cites this paper
• Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy

  2016cites this paper
• Molecular docking studies of dithiocarbamates compounds interactions with jack-bean urease

  2016cites this paper
• Hearing Loss After Cisplatin: Oxidative Stress Pathways and Potential for Protection

  2015cites this paper
• The effect of new palladium (II) complexes of dithiocarbamate derivatives on the morphology and clonogenicity of liver cancer cell line

  2015cites this paper
• Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro.

  2014cites this paper
• Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma.

  2014cites this paper
• An experimental and theoretical approach of spectroscopic and structural properties of the bis(diethyldithiocarbamate)–cobalt(II)

  2012cites this paper
• Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer

  2012cites this paper
• Univerzita Palackého v Olomouci

  2011cites this paper
• Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome.

  2011cites this paper
• Cisplatin: a review of toxicities and therapeutic applications.

  2008cites this paper
• Reduction of cisplatin-induced nephrotoxicity by pyrazolone compounds, derivatives of tetrahydroindazolonedicarboxylic acid.

  2008cites this paper
• EFFECTS OF HYPERBILIRUBINEMIA ON CISPLATIN NEPHROTOXICITY By KARRI ANN BARABAS A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA

  2007cites this paper
• Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals.

  2007cites this paper
• Neuroprotection During Chemotherapy: A Systematic Review

  2007cites this paper
• Multicomponent T2 analysis of dithiocarbamate-mediated peripheral nerve demyelination.

  2007cites this paper
• Systematic Counterion Tuning of the Solid-State Structure of [Pt(thiourea)4]2+

  2007cites this paper
• Neurologic Complications of Therapy

  2006cites this paper
• Quantum Chemical Analysis of the Enantiomerisation Mechanism of Complexes of the Type [MII(XU)4]F+ (M = Pt, Pd, Ni; X = S, Se, Te;U = urea)

  2006cites this paper
• Renal toxicities of chemotherapy.

  2006cites this paper
• D-Methionine attenuated cisplatin-induced vestibulotoxicity through altering ATPase activities and oxidative stress in guinea pigs.

  2006cites this paper
• OTOTOXICIDADE, OTOPROTEÇÃO E AUTODEFESA DAS CÉLULAS CILIADAS DA CÓCLEA

  2005cites this paper
• Diethyldithiocarbamate chemoprotection of carboplatin-induced hematological toxicity

  2005cites this paper
• The importance of schedule on diethyldithiocarbamate modulation of drug-induced myelosuppression

  2004cites this paper
• Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats

  2004cites this paper
• Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review

  2004cites this paper
• WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach

  2004cites this paper
• The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG

  2003cites this paper
• Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites

  2003cites this paper
• Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig.

  2003cites this paper
• Cisplatin nephrotoxicity.

  2003cites this paper
• The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection.

  2003cites this paper
• Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig.

  2003cites this paper
• Amifostine in clinical oncology: current use and future applications

  2002cites this paper
• Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.

  2002cites this paper
• Toxicological testing of cytotoxic drugs (review).

  2001cites this paper
• Anticancer Drug—Induced Kidney Disorders

  2001cites this paper
• Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.

  2000cites this paper
• Effect of protective agents against cisplatin ototoxicity.

  2000cites this paper
• Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig.

  2000cites this paper
• [Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats].

  1999cites this paper
• Cytoprotection in the treatment of pediatric cancer: review of current strategies in adults and their application to children.

  1999cites this paper
• Chemotherapy Side Effects and Their Management

  1999cites this paper
• IL-1beta mediates diethyldithiocarbamate-induced granulocyte colony-stimulating factor production and hematopoiesis.

  1999cites this paper
• Cumulative toxicities from cisplatin therapy and current cytoprotective measures.

  1998cites this paper
• Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.

  1998cites this paper
• Free radicals and antioxidants in chemotherapy-induced toxicity.

  1997cites this paper
• Free radicals and antioxidants in chemotherapyinduced toxicity

  1997cites this paper
• Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates.

  1997cites this paper
• Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system.

  1997cites this paper
• Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.

  1997cites this paper
• The need for cytoprotection.

  1996cites this paper
• D-methionine provides excellent protection from cisplatin ototoxicity in the rat.

  1996cites this paper
• Reducing chemotherapy-associated toxicity in elderly cancer patients.

  1996cites this paper
• A Review of the Modulation of Cisplatin Toxicities by Chemoprotectants

  1996cites this paper
• Neuroprotectant drugs in cisplatin neurotoxicity.

  1996cites this paper
• Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system.

  1995cites this paper
• Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities.

  1995cites this paper
• A Case of Massive Cisplatin Overdose Managed by Plasmapheresis

  1995cites this paper
• Cisplatin nephrotoxicity.

  1994cites this paper
• Complications associated with the treatment of small cell lung cancer.

  1994cites this paper
• A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system

  1994cites this paper
• Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.

  1994cites this paper
• Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management

  1993cites this paper
• Reduction of Cisplatinum-Induced Renal Toxicity in Mice by Tetrahydroindazolone Carboxylic Acid (HIDA)

  1993cites this paper
• Hematopoietic growth factors and chemoprotectants: should we move toward a two-step process for phase I clinical trials in oncology?

  1993cites this paper
• Reduction of cisplatinum-induced renal toxicity in mice by tetrahydroindazolonecarboxylic acid (HIDA) [corrected].

  1993cites this paper
• Prevention and treatment of organ toxicity during high-dose chemotherapy: an overview.

  1993cites this paper
• Renal toxicities of chemotherapy.

  1992cites this paper
• A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.

  1992cites this paper
• Disulfiram and its Metabolite, Diethyldithiocarbamate

  1992influential citation
• Peripheral Neurotoxicity following High-Dose Cisplatin with Glutathione: Clinical and Neurophysiological Assessment

  1992cites this paper
• New therapies for ovarian cancer.

  1992cites this paper
• Diethyldithiocarbamate induction of cytokine release in human long-term bone marrow cultures.

  1992cites this paper
• Probenecid and Diethyldithiocarbamate as Modifiers of Cisplatin Toxicity

  1991cites this paper
• High-Dose Cisplatin with Glutathione Protection in Gynecologic Malignancies

  1991cites this paper
• Cisplatin nephrotoxicity: diethyldithiocarbamate, WR2721, or just water?

  1991cites this paper
• High Dose Cisplatin: Modulation of Toxicity

  1991cites this paper